Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Forest Laboratories Inc (FRX) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Forest Laboratories Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 38074.
Total stock buying since 2010: $140,990,332.
Total stock sales since 2010: $50,089,614.
Total stock option exercises since 2010: $6,324,515.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2014 | 0 | $0 | 635,625 | $42,430,922 | 135,625 | $4,796,106 |
| 2013 | 0 | $0 | 59,197 | $2,239,767 | 35,971 | $975,005 |
| 2012 | 4,100,319 | $140,990,332 | 81,802 | $2,766,139 | 0 | $0 |
| 2011 | 0 | $0 | 54,519 | $1,660,549 | 5,621 | $158,652 |
| 2010 | 0 | $0 | 32,888 | $992,237 | 16,000 | $394,752 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2014-01 | 0 | $0 | 635,625 | $42,430,922 | 135,625 | $4,796,106 |
| 2013-08 | 0 | $0 | 13,104 | $563,431 | 0 | $0 |
| 2013-03 | 0 | $0 | 12,743 | $477,064 | 9,621 | $262,027 |
| 2013-02 | 0 | $0 | 26,350 | $943,303 | 26,350 | $712,978 |
| 2013-01 | 0 | $0 | 7,000 | $255,969 | 0 | $0 |
| 2012-12 | 0 | $0 | 15,942 | $582,249 | 0 | $0 |
| 2012-09 | 393,076 | $13,604,755 | 13,561 | $481,184 | 0 | $0 |
| 2012-08 | 3,707,243 | $127,385,577 | 1,500 | $49,150 | 0 | $0 |
| 2012-04 | 0 | $0 | 8,390 | $292,397 | 0 | $0 |
| 2012-03 | 0 | $0 | 561 | $18,173 | 0 | $0 |
| 2012-01 | 0 | $0 | 41,848 | $1,342,986 | 0 | $0 |
| 2011-12 | 0 | $0 | 38,898 | $1,124,536 | 0 | $0 |
| 2011-06 | 0 | $0 | 5,621 | $206,627 | 5,621 | $158,652 |
| 2011-05 | 0 | $0 | 3,000 | $104,162 | 0 | $0 |
| 2011-03 | 0 | $0 | 7,000 | $225,224 | 0 | $0 |
| 2010-12 | 0 | $0 | 3,888 | $129,007 | 0 | $0 |
| 2010-11 | 0 | $0 | 11,000 | $355,340 | 0 | $0 |
| 2010-08 | 0 | $0 | 17,000 | $479,434 | 16,000 | $394,752 |
| 2010-07 | 0 | $0 | 1,000 | $28,456 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-01-27 | Solomon Howard (Director) | Sale | 21,744 | 64.32 | 1,398,639 |
| 2014-01-24 | Solomon Howard (Director) | Sale | 228,256 | 66.27 | 15,125,612 |
| 2014-01-23 | Solomon Howard (Director) | Sale | 250,000 | 67.13 | 16,782,500 |
| 2014-01-22 | Lynch Jerome (SVP-Sales) | Sale | 135,625 | 67.28 | 9,124,171 |
| 2014-01-22 | Lynch Jerome (SVP-Sales) | Option Ex | 135,625 | 35.36 | 4,796,106 |
| 2013-08-26 | Olanoff Lawrence S (Director) | Sale | 1,104 | 42.96 | 47,431 |
| 2013-08-21 | Francis Perier I Jr (EVP Finance & Admin. & CFO) | Sale | 12,000 | 43.00 | 516,000 |
| 2013-03-07 | Basgoz Nesli (Director) | Sale | 12,200 | 37.47 | 457,097 |
| 2013-03-07 | Basgoz Nesli (Director) | Option Ex | 9,621 | 27.23 | 262,027 |
| 2013-03-04 | Olanoff Lawrence S (Director) | Sale | 543 | 36.77 | 19,967 |
| 2013-02-06 | Meury William (SVP - Marketing) | Sale | 26,350 | 35.80 | 943,303 |
| 2013-02-06 | Meury William (SVP - Marketing) | Option Ex | 26,350 | 27.06 | 712,978 |
| 2013-01-18 | Weinstein Herschel S (SVP General Counsel) | Sale | 7,000 | 36.57 | 255,969 |
| 2012-12-10 | Francis Perier I Jr (EVP Finance & Admin. & CFO) | Sale | 15,942 | 36.52 | 582,249 |
| 2012-09-13 | Icahn Carl C | Buy | 130,232 | 34.57 | 4,502,120 |
| 2012-09-12 | Icahn Carl C | Buy | 245,424 | 34.63 | 8,499,033 |
| 2012-09-06 | Taglietti Marco (Sr.VP-R&D & Chief Medical Off.) | Sale | 13,000 | 35.51 | 461,604 |
| 2012-09-05 | Olanoff Lawrence S (Director) | Sale | 561 | 34.90 | 19,580 |
| 2012-09-05 | Icahn Carl C | Buy | 561 | 34.65 | 19,438 |
| 2012-09-04 | Icahn Carl C | Buy | 16,859 | 34.65 | 584,164 |
| 2012-08-31 | Icahn Carl C | Buy | 6,274 | 34.65 | 217,394 |
| 2012-08-30 | Icahn Carl C | Buy | 63,715 | 34.63 | 2,206,450 |
| 2012-08-29 | Icahn Carl C | Buy | 130,728 | 34.65 | 4,529,725 |
| 2012-08-28 | Icahn Carl C | Buy | 4,052 | 34.64 | 140,361 |
| 2012-08-27 | Icahn Carl C | Buy | 196,626 | 34.65 | 6,813,090 |
| 2012-08-24 | Icahn Carl C | Buy | 152,442 | 34.64 | 5,280,590 |
| 2012-08-23 | Icahn Carl C | Buy | 562,777 | 34.59 | 19,466,456 |
| 2012-08-22 | Icahn Carl C | Buy | 628,618 | 34.53 | 21,706,179 |
| 2012-08-21 | Icahn Carl C | Buy | 732,460 | 34.35 | 25,160,001 |
| 2012-08-20 | Icahn Carl C | Buy | 371,551 | 34.14 | 12,684,751 |
| 2012-08-17 | Icahn Carl C | Buy | 858,000 | 34.01 | 29,180,580 |
| 2012-08-03 | Lynch Jerome (SVP-Sales) | Sale | 1,500 | 32.77 | 49,150 |
| 2012-04-18 | Salans Lester B (Director) | Sale | 2,390 | 34.30 | 81,977 |
| 2012-04-17 | Weinstein Herschel S (SVP General Counsel) | Sale | 6,000 | 35.07 | 210,420 |
| 2012-03-07 | Olanoff Lawrence S (Director) | Sale | 561 | 32.39 | 18,173 |
| 2012-01-18 | Meury William (SVP - Marketing) | Sale | 41,848 | 32.09 | 1,342,986 |
| 2011-12-15 | Lynch Jerome (SVP-Sales) | Sale | 14,000 | 28.80 | 403,200 |
| 2011-12-14 | Francis Perier I Jr (EVP Finance & Admin. & CFO) | Sale | 10,000 | 28.55 | 285,540 |
| 2011-12-13 | Hochberg Elaine (EVP & CCO) | Sale | 14,898 | 29.25 | 435,796 |
| 2011-06-08 | Zimetbaum Peter J. (Director) | Sale | 5,621 | 36.76 | 206,627 |
| 2011-06-08 | Zimetbaum Peter J. (Director) | Option Ex | 5,621 | 28.23 | 158,652 |
| 2011-05-23 | Taglietti Marco (Sr.VP-R&D & Chief Medical Off.) | Sale | 3,000 | 34.72 | 104,162 |
| 2011-03-10 | Weinstein Herschel S (VP General Counsel) | Sale | 7,000 | 32.17 | 225,224 |
| 2010-12-16 | Candee William J Iii (Director) | Sale | 3,888 | 33.18 | 129,007 |
| 2010-11-24 | Candee William J Iii (Director) | Sale | 8,000 | 32.15 | 257,192 |
| 2010-11-18 | Taglietti Marco (Exec. VP-Chief Medical Officer) | Sale | 3,000 | 32.72 | 98,148 |
| 2010-08-23 | Salans Lester B (Director) | Sale | 1,000 | 27.83 | 27,826 |
| 2010-08-09 | Candee William J Iii (Director) | Sale | 8,000 | 28.45 | 227,608 |
| 2010-08-09 | Candee William J Iii (Director) | Option Ex | 8,000 | 24.67 | 197,376 |
| 2010-08-06 | Cohan George S (Director) | Sale | 8,000 | 28.00 | 224,000 |
| 2010-08-06 | Cohan George S (Director) | Option Ex | 8,000 | 24.67 | 197,376 |
| 2010-07-22 | Basgoz Nesli (Director) | Sale | 1,000 | 28.46 | 28,456 |
Insider trading activities including stock purchases, stock sales, and option exercises of FRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Forest Laboratories Inc (symbol FRX, CIK number 38074) see the Securities and Exchange Commission (SEC) website.